The EU collaboration with international partners on generics

The EU is leading an international pilot project.

The EU is leading an international pilot project through which, upon request from a generic pharmaceutical company, it will share the assessment reports generated as part of the decentralised procedure in real time with collaborating regulatory agencies outside the EU.
This should enable medicines to be authorised in different territories in a coordinated way at approximately the same time.

Original source


Register for receiving PharmaAround news, register for PharmAround events.
Continue registration